A similar bill was introduced last month in the House of Representatives and was sponsored by Rep. Bobby Rush, D-Ill., Reps. Scott Peters, D-Calif., Neal Dunn, R-Fla. and Greg Murphy, R-N.C. “We cannot tolerate a two-tiered health care system — one for the rich, and one for everyone else. Unfortunately, many low-income and minority patients are being denied access to the most efficient tests, therapies, and care due to the current payment structure for diagnostic radiopharmaceuticals that makes it nearly impossible for many hospitals serving our most vulnerable populations to offer these lifesaving diagnostics. The FIND Act is important legislation to help fix this disparity,” said Rep. Rush.

The FIND Act is also expected to help address racial disparities in healthcare created by the disproportionate impact of Alzheimer’s disease, prostate cancer and other serious conditions on black Americans and other minority communities.


"We applaud the Senate introduction of this bill which will ensure patient access to the lifesaving benefits of these innovative diagnostic radiopharmaceuticals, rectifying inequitable reimbursement due to CMS payment policies," stated Cathy Cutler, SNMMI government relations committee and committee on radiopharmaceuticals chair.

Back to HCB News

Molecular Imaging Homepage